-
EP1535630
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1535630
| EP1535630 - PREVENTIVE FOR THE ONSET OF DIABETES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 29.02.2008 Database last updated on 02.11.2024 | Most recent event Tooltip | 29.02.2008 | Withdrawal of application | published on 02.04.2008 [2008/14] | Applicant(s) | For all designated states Sankyo Company, Limited 5-1, Nihonbashi Honcho 3-chome, Chuo-ku Tokyo 103-8426 / JP | [N/P] |
| Former [2005/22] | For all designated states Sankyo Company, Limited 5-1, Nihonbashi Honcho 3-chome, Chuo-ku Tokyo 103-8426 / JP | Inventor(s) | 01 /
YOSHIDA, Taishi, SANKYO COMPANY, LIMITED 2-58, Hirromachi 1-chome, Shinagawa-ku Tokyo 140-8710 / JP | 02 /
OKUNO, Akira, SANKYO COMPANY, LIMITED 2-58, Hirromachi 1-chome, Shinagawa-ku Tokyo 140-8710 / JP | [2005/22] | Representative(s) | Gibson, Christian John Robert, et al Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | [N/P] |
| Former [2005/22] | Gibson, Christian John Robert, et al Marks & Clerk 90 Long Acre London WC2E 9RA / GB | Application number, filing date | 03765368.0 | 23.07.2003 | [2005/22] | WO2003JP09348 | Priority number, date | JP20020213898 | 23.07.2002 Original published format: JP 2002213898 | JP20020366844 | 18.12.2002 Original published format: JP 2002366844 | [2005/22] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004009118 | Date: | 29.01.2004 | Language: | EN | [2004/05] | Type: | A1 Application with search report | No.: | EP1535630 | Date: | 01.06.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.01.2004 takes the place of the publication of the European patent application. | [2005/22] | Search report(s) | International search report - published on: | JP | 29.01.2004 | Classification | IPC: | A61K45/00, A61K31/4985, A61K31/517, A61K31/675, A61P3/10, A61P9/10, A61P9/12, A61P43/00, C07D239/94, C07D417/12, C07D471/04 | [2005/22] | CPC: |
A61K31/4985 (EP,US);
A61K31/00 (EP,US);
A61K31/517 (EP,US);
A61K31/675 (EP,US);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/22] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | MITTEL ZUR VERHINDERUNG DES AUFTRETENS VON DIABETES | [2005/22] | English: | PREVENTIVE FOR THE ONSET OF DIABETES | [2005/22] | French: | PROPHYLACTIQUE CONTRE L'APPARITION DES DIABETES | [2005/22] | Entry into regional phase | 13.01.2005 | Translation filed | 12.01.2005 | National basic fee paid | 12.01.2005 | Search fee paid | 12.01.2005 | Designation fee(s) paid | 12.01.2005 | Examination fee paid | Examination procedure | 23.07.2003 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 13.01.2005 | Amendment by applicant (claims and/or description) | 13.01.2005 | Examination requested [2005/22] | 22.02.2008 | Application withdrawn by applicant [2008/14] | Fees paid | Renewal fee | 13.07.2005 | Renewal fee patent year 03 | 12.07.2006 | Renewal fee patent year 04 | 13.07.2007 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0147935 (METS ASIS THERAPEUTICS INC [US]); | [X]WO9947549 (ONTOGEN CORP [US]); | [XP] - WRIGHT S.W. ET AL., "Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis,In Vitro Characterization,and X-ray Crystallography", J. MED. CHEM., (20020829), vol. 45, no. 18, pages 3865 - 3877, XP002973569 DOI: http://dx.doi.org/10.1021/jm010496a | [X] - WRIGHT S.W. ET AL., "Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazo lines", BIOORG. MED. CHEM. LETT., (20010108), vol. 11, no. 1, pages 17 - 21, XP004225313 DOI: http://dx.doi.org/10.1016/S0960-894X(00)00586-2 | [Y] - KNOWLER W.C. ET AL., "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", MEDLINE, Database accession no. 11832527, XP002973566 | [ ] - N. ENGL. J. MED., (20020207), vol. 346, no. 6, pages 393 - 403 | [Y] - SARTOR G. ET AL., "Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation", MEDLINE, Database accession no. 7380107, XP000938566 DOI: http://dx.doi.org/10.2337/diabetes.29.1.41 | [ ] - DIABETES, (198001), vol. 29, no. 1, pages 41 - 49 | [Y] - NOLAN J.J. ET AL., "Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone", MEDLINE, Database accession no. 7935656, XP002973567 | [ ] - N. ENGL. J. MED., (19941103), vol. 331, no. 18, pages 1188 - 1193 | [Y] - ANTONUCCI T. ET AL., "Impaired glucose tolerance is normalized by treatment with the thiazolidine dione troglitazone", MEDLINE, Database accession no. 9118772, XP002973568 | [ ] - DIABETES CARE, (199702), vol. 20, no. 2, pages 188 - 193 |